News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
First-Line Procarbazine, CCNU, and Vincristine With Radiotherapy in IDH-Mutant Oligodendroglioma – Journal of Clinical Oncology
 Salah Eddine O. Kacimi/researchgate.net
Oct 15, 2024, 16:40

First-Line Procarbazine, CCNU, and Vincristine With Radiotherapy in IDH-Mutant Oligodendroglioma – Journal of Clinical Oncology

Journal of Clinical Oncology shared a post on X:

“Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.”

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma

Authors: Salah Eddine O. Kacimi, et al.

 

First-Line Procarbazine, CCNU, and Vincristine With Radiotherapy in IDH-Mutant Oligodendroglioma - Journal of Clinical Oncology

cancer cancer awareness cancer care CCNU fight against cancer Global fight against cancer JCO Journal of Clinical Oncology Oligodendroglioma OncoDaily Oncology Procarbazine radiotherapy Salah Eddine O. Kacimi
Special Coverage
Insight
Oct 15, 2024, 19:00
The use of TDXd for patients with Metastatic, HER2-low and HER2-ultralow Breast Cancer - Dana-Farber’s Breast Oncology Center
Blog
Oct 15, 2024, 18:57
Narjust Florez: Tip No. 6 for that transition from training to attending
Blog
Oct 15, 2024, 18:54
Shahrin Ahmed on combination therapy for Triple Negative Breast Cancer treatment
Blog
Oct 15, 2024, 17:41
Narjust Florez: Tip No. 5 of that transition from training to attending
Blog
Oct 15, 2024, 17:37
Gerard Walls: Submit your abstract for 23rd BTOG Annual Conference 2025
Blog
Oct 15, 2024, 17:36
Yakup Ergün: Classification of Ovarian Epithelial Tumors
Blog
Oct 15, 2024, 17:32
Estela Rodriguez: Always an honor to be ASCO headquarters
Blog
Oct 15, 2024, 17:29
Jill Feldman: Interesting finding for people with EFGR lung cancer that transforms to SCLC
Blog
Oct 15, 2024, 17:26
BreastScreen SA will now offer Sensory Friendly Clinics
Insight
Oct 15, 2024, 17:20
A Croatian version of the ESMO Patient Guide on Bone Health in Cancer
Insight
Oct 15, 2024, 17:18
Laura Samá: Learning curve in retroperitoneal sarcoma surgery
Insight
Oct 15, 2024, 17:16
Olubukola Ayodele: Critical Discussion on Cancer Health Disparities at the House of Commons